| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
|
Nat Med
|
2013
|
9.44
|
|
2
|
High-fat diet determines the composition of the murine gut microbiome independently of obesity.
|
Gastroenterology
|
2009
|
5.08
|
|
3
|
The human gut virome: inter-individual variation and dynamic response to diet.
|
Genome Res
|
2011
|
3.32
|
|
4
|
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract.
|
Proc Natl Acad Sci U S A
|
2004
|
3.05
|
|
5
|
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
|
Gastroenterology
|
2007
|
2.55
|
|
6
|
Rapid evolution of the human gut virome.
|
Proc Natl Acad Sci U S A
|
2013
|
2.53
|
|
7
|
Associating microbiome composition with environmental covariates using generalized UniFrac distances.
|
Bioinformatics
|
2012
|
2.19
|
|
8
|
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity.
|
J Immunol
|
2004
|
2.09
|
|
9
|
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.
|
J Clin Invest
|
2006
|
1.66
|
|
10
|
Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents.
|
PLoS One
|
2013
|
1.64
|
|
11
|
Hypervariable loci in the human gut virome.
|
Proc Natl Acad Sci U S A
|
2012
|
1.58
|
|
12
|
Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis.
|
J Immunol
|
2007
|
1.55
|
|
13
|
Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein.
|
Gastroenterology
|
2003
|
1.53
|
|
14
|
Structure-constrained sparse canonical correlation analysis with an application to microbiome data analysis.
|
Biostatistics
|
2012
|
1.49
|
|
15
|
Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine.
|
Am J Physiol Gastrointest Liver Physiol
|
2004
|
1.31
|
|
16
|
A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples.
|
Genome Biol
|
2012
|
1.17
|
|
17
|
Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment.
|
PLoS One
|
2013
|
1.11
|
|
18
|
Molecular cloning and promoter analysis of downregulated in adenoma (DRA).
|
Am J Physiol Gastrointest Liver Physiol
|
2007
|
1.07
|
|
19
|
Functional coupling of the downregulated in adenoma Cl-/base exchanger DRA and the apical Na+/H+ exchangers NHE2 and NHE3.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
1.01
|
|
20
|
FIZZ2/RELM-β induction and role in pulmonary fibrosis.
|
J Immunol
|
2011
|
1.01
|
|
21
|
Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance.
|
Immunity
|
2013
|
1.00
|
|
22
|
Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
|
Inflamm Bowel Dis
|
2015
|
0.99
|
|
23
|
Food and the gut microbiota in inflammatory bowel diseases: a critical connection.
|
Curr Opin Gastroenterol
|
2012
|
0.98
|
|
24
|
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.
|
Inflamm Bowel Dis
|
2013
|
0.97
|
|
25
|
Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing.
|
Genome Biol
|
2014
|
0.96
|
|
26
|
Conservation of gene cassettes among diverse viruses of the human gut.
|
PLoS One
|
2012
|
0.96
|
|
27
|
Divergent metabolic adaptations to intestinal parasitic nematode infection in mice susceptible or resistant to obesity.
|
Gastroenterology
|
2007
|
0.93
|
|
28
|
Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
|
Inflamm Bowel Dis
|
2015
|
0.91
|
|
29
|
Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaB-dependent mechanism.
|
Neurobiol Dis
|
2002
|
0.89
|
|
30
|
Engineering the gut microbiota to treat hyperammonemia.
|
J Clin Invest
|
2015
|
0.89
|
|
31
|
The gut microbiota, environment and diseases of modern society.
|
Gut Microbes
|
2012
|
0.88
|
|
32
|
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.
|
Inflamm Bowel Dis
|
2012
|
0.86
|
|
33
|
Is there a role for PPAR gamma in IBD? Yes, no, maybe.
|
Gastroenterology
|
2003
|
0.85
|
|
34
|
Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
0.84
|
|
35
|
Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts.
|
Inflamm Bowel Dis
|
2015
|
0.80
|
|
36
|
The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease.
|
Nestle Nutr Inst Workshop Ser
|
2016
|
0.78
|
|
37
|
Nuclear hormone receptors and intestinal inflammation.
|
Gastroenterology
|
2007
|
0.77
|
|
38
|
Diet, gut enterotypes and health: is there a link?
|
Nestle Nutr Inst Workshop Ser
|
2013
|
0.76
|
|
39
|
The promise and challenges of biobanking in digestive disease research.
|
Gastroenterology
|
2009
|
0.75
|
|
40
|
Nutrition, gut microbiota and immunity: therapeutic targets for IBD. Concluding remarks.
|
Nestle Nutr Inst Workshop Ser
|
2014
|
0.75
|
|
41
|
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.
|
Cell Host Microbe
|
2017
|
0.75
|